International Journal of Hematology and Oncology 2023, Vol 33, Num 4 Page(s): 166-170
Orbital Exenterations: Our experience at Ankara Oncology Research And Training Hospital

Rahmi DUMAN1, Mehmet BALCI1, Reşat DUMAN2, Sibel OZDOGAN1

1Ankara Oncology Hospital, Department of Ophthalmology, Ankara
2Emirdağ Hospital, Department of Ophthalmology, Afyon, TURKEY

Keywords: Orbital exenteration, Orbital tumour, Squamous cell carcinoma, Basal cell carcinoma, Eyelid sebaceous carcinoma
The aim of this study is to review our 5 year experience with orbital exenterations and to evaluate the demographic and clinical features of patients, indications and outcomes. Between January 2008 and December 2012, 16 patients who underwent orbital exenteration were included in the study. Most of the lesions originated from eyelid (n= 14) and remaining 2 lesions originated from orbit. Histopathological examination of the lesions were consistent with basal cell carcinoma (n= 7), squamous cell carcinoma (n=5), sebaceous carcinoma (n= 2), choroidal melanoma (n= 1) and adenoid cystic carcinoma (n= 1). Secondary orbital tumours are the major indication for orbital exenteration. Aggressive removal of primary tumours can reduce the frequency of this disfiguring procedure.